GLP-1 Medications See Surge in Use for Weight Loss and Potential Addiction Treatment

These drugs, originally for diabetes, are now widely prescribed for obesity and show promise in addiction research.

The FDA's approval of Wegovy for adolescents has led to a significant increase in GLP-1 prescriptions among teens, with prescriptions rising over 500% since 2020.
GLP-1 receptor agonists like Ozempic and Wegovy are noted for their ability to aid weight loss by reducing appetite and improving metabolic health.
Research suggests these medications may also help reduce cravings associated with substance use disorders, although more clinical studies are needed.
Despite their benefits, GLP-1 drugs come with potential side effects, including gastrointestinal issues and, in rare cases, more severe health risks.
Experts emphasize the importance of combining these medications with lifestyle changes, such as diet and exercise, for effective long-term weight management.